Limits...
Medicaid spending and utilization for central nervous system drugs.

Baugh DK, Pine PL, Blackwell S, Ciborowski G - Health Care Financ Rev (2004)

Bottom Line: The analysis examines cost variation by census region, State, Medicaid basis of eligibility, and therapeutic use of drugs.In 1998, the highest expenditures were for central nervous system (CNS) drugs and for anti-psychotics compared to three other groups of CNS drugs (anti-anxiety agents, anti-depressants, and hypnotics).There were major variations among SMRF States and their respective regions.

View Article: PubMed Central - PubMed

Affiliation: Centers for Medicare & Medicaid Services (CMS), Baltimore, MD 21244-1850, USA. dbaugh@cms.hhs.gov

ABSTRACT
Prior research has shown that prescription drug spending grew substantially during the decade of the 1990s. This analysis uses 1996 to 1998 State Medicaid Research File (SMRF) fee-for-service (FFS) data for 29 participating States to provide insight into the factors driving this growth. The analysis examines cost variation by census region, State, Medicaid basis of eligibility, and therapeutic use of drugs. In 1998, the highest expenditures were for central nervous system (CNS) drugs and for anti-psychotics compared to three other groups of CNS drugs (anti-anxiety agents, anti-depressants, and hypnotics). By eligibility group, expenditures were typically highest for disabled enrollees. There were major variations among SMRF States and their respective regions.

Show MeSH

Related in: MedlinePlus

Medicaid Central Nervous System (CNS) Drug Prescriptions for 29 SMRF States, by Basis of Eligibility: 1996-1998Disabled Medicaid Recipients Clearly Used More Prescription CNS Drugs Than Any Other Eligibility Group From 1996 to 1998 in the 29 SMRF StatesThe disabled accounted for 16.3 million prescriptions in 1996, 16.5 million in 1997, and 15.7 million in 1998. The trend in fewer prescriptions is true for all four eligibility groups. From 1996 to 1998 disabled Medicaid recipients received 15 times the number of prescriptions that children received.Each of the four eligibilty groups had fewer prescriptions dispensed in 1998 than in 1996. Adults had the greatest decrease in number from 1.90 million in 1996 to 1.26 million in 1998.In 1996 there were 26.1 million FFS CNS drug prescriptions dispensed for all groups compared to 24.7 million in 1998. Why does it appear that CNS prescription drug use among Medicaid recipients decreased? One possible explanation could be the increased enrollment in prepaid plans from 1996 to 1998 in these States. Reporting number of prescriptions paid by prepaid plans is unreliable at this time. However, in the same period in which the number of prescriptions declined, CNS drug payments increased by 63.9 percent.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4194875&req=5

f4-hcfr-26-1-057: Medicaid Central Nervous System (CNS) Drug Prescriptions for 29 SMRF States, by Basis of Eligibility: 1996-1998Disabled Medicaid Recipients Clearly Used More Prescription CNS Drugs Than Any Other Eligibility Group From 1996 to 1998 in the 29 SMRF StatesThe disabled accounted for 16.3 million prescriptions in 1996, 16.5 million in 1997, and 15.7 million in 1998. The trend in fewer prescriptions is true for all four eligibility groups. From 1996 to 1998 disabled Medicaid recipients received 15 times the number of prescriptions that children received.Each of the four eligibilty groups had fewer prescriptions dispensed in 1998 than in 1996. Adults had the greatest decrease in number from 1.90 million in 1996 to 1.26 million in 1998.In 1996 there were 26.1 million FFS CNS drug prescriptions dispensed for all groups compared to 24.7 million in 1998. Why does it appear that CNS prescription drug use among Medicaid recipients decreased? One possible explanation could be the increased enrollment in prepaid plans from 1996 to 1998 in these States. Reporting number of prescriptions paid by prepaid plans is unreliable at this time. However, in the same period in which the number of prescriptions declined, CNS drug payments increased by 63.9 percent.


Medicaid spending and utilization for central nervous system drugs.

Baugh DK, Pine PL, Blackwell S, Ciborowski G - Health Care Financ Rev (2004)

Medicaid Central Nervous System (CNS) Drug Prescriptions for 29 SMRF States, by Basis of Eligibility: 1996-1998Disabled Medicaid Recipients Clearly Used More Prescription CNS Drugs Than Any Other Eligibility Group From 1996 to 1998 in the 29 SMRF StatesThe disabled accounted for 16.3 million prescriptions in 1996, 16.5 million in 1997, and 15.7 million in 1998. The trend in fewer prescriptions is true for all four eligibility groups. From 1996 to 1998 disabled Medicaid recipients received 15 times the number of prescriptions that children received.Each of the four eligibilty groups had fewer prescriptions dispensed in 1998 than in 1996. Adults had the greatest decrease in number from 1.90 million in 1996 to 1.26 million in 1998.In 1996 there were 26.1 million FFS CNS drug prescriptions dispensed for all groups compared to 24.7 million in 1998. Why does it appear that CNS prescription drug use among Medicaid recipients decreased? One possible explanation could be the increased enrollment in prepaid plans from 1996 to 1998 in these States. Reporting number of prescriptions paid by prepaid plans is unreliable at this time. However, in the same period in which the number of prescriptions declined, CNS drug payments increased by 63.9 percent.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4194875&req=5

f4-hcfr-26-1-057: Medicaid Central Nervous System (CNS) Drug Prescriptions for 29 SMRF States, by Basis of Eligibility: 1996-1998Disabled Medicaid Recipients Clearly Used More Prescription CNS Drugs Than Any Other Eligibility Group From 1996 to 1998 in the 29 SMRF StatesThe disabled accounted for 16.3 million prescriptions in 1996, 16.5 million in 1997, and 15.7 million in 1998. The trend in fewer prescriptions is true for all four eligibility groups. From 1996 to 1998 disabled Medicaid recipients received 15 times the number of prescriptions that children received.Each of the four eligibilty groups had fewer prescriptions dispensed in 1998 than in 1996. Adults had the greatest decrease in number from 1.90 million in 1996 to 1.26 million in 1998.In 1996 there were 26.1 million FFS CNS drug prescriptions dispensed for all groups compared to 24.7 million in 1998. Why does it appear that CNS prescription drug use among Medicaid recipients decreased? One possible explanation could be the increased enrollment in prepaid plans from 1996 to 1998 in these States. Reporting number of prescriptions paid by prepaid plans is unreliable at this time. However, in the same period in which the number of prescriptions declined, CNS drug payments increased by 63.9 percent.
Bottom Line: The analysis examines cost variation by census region, State, Medicaid basis of eligibility, and therapeutic use of drugs.In 1998, the highest expenditures were for central nervous system (CNS) drugs and for anti-psychotics compared to three other groups of CNS drugs (anti-anxiety agents, anti-depressants, and hypnotics).There were major variations among SMRF States and their respective regions.

View Article: PubMed Central - PubMed

Affiliation: Centers for Medicare & Medicaid Services (CMS), Baltimore, MD 21244-1850, USA. dbaugh@cms.hhs.gov

ABSTRACT
Prior research has shown that prescription drug spending grew substantially during the decade of the 1990s. This analysis uses 1996 to 1998 State Medicaid Research File (SMRF) fee-for-service (FFS) data for 29 participating States to provide insight into the factors driving this growth. The analysis examines cost variation by census region, State, Medicaid basis of eligibility, and therapeutic use of drugs. In 1998, the highest expenditures were for central nervous system (CNS) drugs and for anti-psychotics compared to three other groups of CNS drugs (anti-anxiety agents, anti-depressants, and hypnotics). By eligibility group, expenditures were typically highest for disabled enrollees. There were major variations among SMRF States and their respective regions.

Show MeSH
Related in: MedlinePlus